Skip to main content

Peer Review reports

From: The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial

Original Submission
16 Aug 2022 Submitted Original manuscript
17 Oct 2022 Reviewed Reviewer Report
19 Oct 2022 Reviewed Reviewer Report
19 Nov 2022 Author responded Author comments - Lin-Quan Tang
Resubmission - Version 2
19 Nov 2022 Submitted Manuscript version 2
29 Nov 2022 Reviewed Reviewer Report
6 Dec 2022 Reviewed Reviewer Report
30 Dec 2022 Author responded Author comments - Lin-Quan Tang
Resubmission - Version 3
30 Dec 2022 Submitted Manuscript version 3
Publishing
16 Feb 2023 Editorially accepted
16 Mar 2023 Article published 10.1186/s12916-023-02790-1

You can find further information about peer review here.

Back to article page